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 Abstract    
Objective: The objective of this study was to determine the relationship between the hemoglobin levels during the 
first trimester of pregnancy with gestational diabetes incidence in pregnant women.
Materials and methods: This is a prospective cohort study on 700 pregnant women with gestational ages of 
1-13 weeks. Sampling was performed using the convenience method. For each pregnant woman, the hemoglobin 
level of the first trimester of pregnancy was measured. All the cases were followed up to delivery due to gestational 
diabetes.
Results: Hemoglobin levels were categorized into three groups (<1.1, 1.1-1.24, ≥1.25 g/L). The data were extracted 
using the SPSS, and analyzed with descriptive and inferential statistics. Statistical tests revealed a significant 
difference among the three groups in hemoglobin levels and gestational diabetes incidence (p<0.001). Women with 
higher hemoglobin levels were at an increased risk of developing gestational diabetes (RR=3.94, 95% CI=1.73-
8.95).
Conclusion: It appears that hemoglobin level during the first trimester of pregnancy may be considered as a 
selective screening factor for gestational diabetes.
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Introduction
Diabetes	 is	 counted	 among	 the	most	 important	 healthcare	
and	 socio-economic	 challenges	 of	 the	 contemporary	world	 [1-	
2].	Gestational	diabetes	is	a	subtype	of	diabetes,	manifesting	as	
carbohydrate	 intolerance	 of	 varying	 degrees,	 occurring	 for	 the	
first	time	during	pregnancy	[2-	3].	
The	worldwide	prevalence	of	 gestational	 diabetes	 is	 2-5%	
[3-4].	 Recent	 studies	 have	 indicated	 that	 the	 prevalence	 of	
gestational	 diabetes	 is	 increasing	 in	 all	 ethnic	 groups,	 rising	
by	 about	 40%	 from	 1989	 to	 2002	 [5-8].	The	 first	 trimester	 of	
pregnancy	is	accompanied	by	changes	in	insulin	sensitivity	and,	
as	 the	 embryo	develops,	 insulin	 secretion	 is	 augmented	due	 to	
insulin	resistance.	This	resistance	reaches	its	peak	during	the	third	
trimester,	what	is	caused	by	hormonal	changes.	The	physiologic	
changes	 of	 pregnancy	 may	 result	 in	 gestational	 diabetes	 in	
individuals	 who	 are	 prone	 to	 it	 [9-	 12].	 Hence,	 pregnancy	 is	
considered	to	be	a	diabetogenic	state	and	gestational	diabetes	is	
the	most	frequent	metabolic	disorder	during	this	period	[13-14].	
Gestational	diabetes	 is	associated	with	 increased	complications	
and	undesirable	outcomes	of	pregnancy,	and	may	result	in	long-
term	 complications	 for	 both	 the	mother	 and	 the	 newborn	 [15-	
17].	 Early	 diagnosis	 of	 patients	with	 gestational	 diabetes	 is	 of	
utmost	 importance,	because	appropriate	 therapy	may	minimize	
maternal	 and	 neonatal	 complications	 [9,	 18-19].	 Few	 studies	
have	dealt	with	high	hemoglobin	levels	and	increased	incidence	
of	gestational	diabetes	[3,	17].	Although	high	level	of	maternal	
hemoglobin	 is	 erroneously	 considered	 to	 herald	 health	 and	 its	
impact	on	the	outcome	of	pregnancy	does	not	receive	as	much	
attention	 as	 that	 of	 anemia	 [15,	 18,	 20],	 there	 is	 considerable	
evidence	in	developed	countries	indicating	that	the	complications	
of	increased	hemoglobin	may	be	as	detrimental,	if	not	worse,	as	
low	 hemoglobin	 levels	 [19,	 21].	 Some	 researchers,	 however,	
believe	 that	 high	 concentrations	 of	 maternal	 hemoglobin	 have	
never	 been	 definitely	 proven	 to	 be	 a	 risk	 factor	 for	 pregnant	
women	[22].	
Considering	this	controversial	issue,	we	decided	to	conduct	
a	 study	 in	 order	 to	 determine	 the	 relationship	 between	 the	
hemoglobin	 levels	 during	 the	first	 trimester	 of	 pregnancy	with	
the	 incidence	 of	 gestational	 diabetes	 in	women	 referred	 to	 the	
Milad	Hospital,	Tehran	in	2010.
Method
This	 is	 an	 analytical,	 prospective,	 cohort	 study	 conducted	
with	 convenience	 sampling	 from	 October	 2009	 to	 August	
2010.	Sample	size	was	determined	as	follows:	700	people	with	
a	 confidence	 interval	 of	 95%,	 relative	 accuracy	 of	 25%	 and	 a	
probability	of	exclusion	of	10%.
The	Ethics	Committee	at	the	International	Branch	of	Shahid	
Beheshti	University	of	Medical	Sciences	approved	of	our	study	
(license	number	116/995).	Once	all	the	necessary	authorizations	
were	 acquired,	 the	 researchers	 referred	 to	 the	Milad	 Hospital,	
Tehran,	in	order	to	explain	the	nature	and	objectives	of	the	study	
and	 to	 recruit	 700	 pregnant	 women	 who	 were	 referred	 to	 the	
pregnancy	 care	 clinics	 and	 fulfilled	 the	 inclusion	 criteria.	All	
women	gave	their	written	informed	consent.	Data	were	collected	
using	 a	 questionnaire	 containing	 personal	 data	 and	 obstetric	
history.	 The	 validity	 and	 reliability	 of	 the	 questionnaire	 were	
assessed	 using	 content	 validity	 and	 test	 re-test,	 respectively.	
Researchers	 completed	 the	 questionnaires	 through	 interviews	
with	the	cases.	Complete	blood	counts	(CBC)	were	obtained	from	
all	cases	to	measure	the	hemoglobin	level	of	the	first	trimester.	In	
addition,	glucose	challenge	test	(GCT)	with	50	g	of	glucose	was	
performed	as	the	national	routine	test	for	pregnant	women	in	24-
28	weeks	of	gestational	 age.	For	 those	women	who	had	blood	
sugar	 levels	 higher	 than	 140	mg/dL	 on	 the	GCT,	 oral	 glucose	
tolerance	 test	 (OGTT)	was	 performed	 at	 the	 laboratory	 of	 the	
Milad	Hospital	 in	 order	 to	 establish	 a	 diagnosis	 of	 gestational	
diabetes,	 and	 the	 results	were	 extracted	by	 the	 researchers	 and	
recorded	on	data	sheets.
Based	on	hemoglobin	level,	the	samples	were	categorized	in	
three	groups	of	Low	(<1.1	g/L),	Normal	(1.1-1.24	g/L)	and	High	
(≥1.25	g/L)	[20].
 Streszczenie   
Cel pracy: Celem pracy była ocena związku pomiędzy poziomem hemoglobiny w pierwszym trymestrze u ciężarnej 
z cukrzycą ciążową.
Materiał i metoda: Prospektywne kohortowe badanie przeprowadzono na 700 kobietach w 1-13 tygodniu ciąży. 
U każdej kobiety badano poziom hemoglobiny w pierwszym trymestrze ciąży. Wszystkie przypadki kontrolowano 
aż do porodu ze względu na cukrzycę.
Wyniki: Wyznaczono trzy grupy w zależności od poziomu hemoglobiny (<1.1, 1.1-1.24, ≥1.25g/L). Uzyskane dane 
analizowano przy pomocy SPSS stosując statystykę opisową i wnioskowanie statystyczne. Testy statystyczne 
wykazały istotną różnicę pomiędzy trzema grupami w poziomie hemoglobiny i częstości występowania cukrzycy 
ciążowej (p<0.001). Kobiety z wyższym poziomem hemoglobiny były w grupie zwiększonego ryzyka rozwoju 
cukrzycy ciążowej (RR=3.94, 95%CI=1.73-8.95).
Wnioski: Wydaje się, że poziom hemoglobiny w pierwszym trymestrze ciąży może być selektywnym czynnikiem 
skriningowym cukrzycy ciążowej.
 Słowa kluczowe: pierwszy trymestr / cukrzyca ciążowa / hemoglobina / 
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All	cases	were	followed	up	to	the	delivery	due	to	developing	
gestational	diabetes	and	the	supplements,	duration	of	intake	and	
their	 types	were	 recorded	 on	 each	 visit.	 The	 inclusion	 criteria	
were:	 a	pregnant	woman	with	a	 single	 fetus,	 aged	18-35	years	
with	a	gestational	age	of	1-13	weeks	(calculated	using	 the	first	
day	of	the	last	regular	menstruation	or	a	sonography	report	during	
the	first	trimester),	a	parity	of	3	or	less,	lack	of	known	systemic	
diseases,	 and	 lack	 of	 gestational	 diabetes	 during	 previous	
pregnancies.
The	Carpenter	and	Coustan	criteria	were	used	for	diagnosing	
diabetes	 –	 fasting	 blood	 sugar	 of	 95	 mg/dL,	 1-hour,	 2-hour,	
and	 3-hour	 blood	 sugar	 levels	 of	 180,	 155,	 and	 130	 mg/dL,	
respectively,	following	oral	consumption	of	100	g	of	glucose).
The	researcher	and	3	trained	colleagues	determined	the	type	
of	delivery,	gestational	age	and	neonatal	weight	in	the	labor	room	
and	 recorded	 the	 information	on	data	 sheets.	The	 reliability	 of	
data	measurement	and	 recordings	was	assessed	by	4	midwives	
using	the	inter	rater	consistency.
The	 exclusion	 criteria	 were:	 development	 of	 known	 fetal	
anomalies,	abortion,	stillbirth,	consumption	of	alcohol,	cigarettes	
or	non-routine	drugs	during	the	present	pregnancy	or	receiving	
pregnancy	care	or	tests	in	other	centers.	Hemoglobin	levels	were	
measured	by	a	 laboratory	expert	at	 the	 laboratory	of	 the	Milad	
Hospital	by	flow	cytometry	on	a	Sysmex	XT	1800i	cell	counter	
(Adons	Electronics,	Japan).	Blood	sugar	was	measured	using	the	
GOD/PAP	method	and	kits	prepared	by	ParsAzmoon	(licensed	by	
Germany)	on	Hitachi	902	instruments	manufactured	in	Japan.	All	
the	 instruments	were	 calibrated	every	morning	by	a	 laboratory	
expert	and	their	accuracy	and	reliability	were	ascertained.	Data	
analysis	was	performed	using	the	SPSS	software	version	18	with	
statistical	tests	of	Kruskal-Wallis,	chi-square,	one-way	ANOVA,	
relative	risk	and	logistic	regression	model.	The	confidence	interval	
and	level	of	significance	were	95%	and	<0.05,	respectively.	
Results
From	the	700	women	who	entered	our	study,	a	total	of	100	
were	 excluded	 due	 to	 lack	 of	 compliance	 (16	 cases),	 abortion	
(15	cases),	 intrauterine	fetal	demise	(9	cases),	oligohydramnios	
(36	cases),	polyhydramnios	(4	cases),	placenta	previa	(9	cases),	
placental	abruption	(8	cases),	and	neonatal	anomalies	(3	cases),	
thus	leaving	600	women	for	investigation.	
The	demographic	and	obstetric	characteristics	of	our	cases	
are	 summarized	 in	Table	 I:	 343	 (57.2%)	of	 the	 patients	 fell	 in	
the	age	range	of	25-30	years.	Their	mean	age	was	27.28	years,	
with	 a	 standard	 deviation	 of	 3.94.	 419	 (69.8%)	 of	 the	 study	
participants	 had	 intermediate/high	 school	 education	 and	 502	
(83.7%)	were	housewives.	289	(48.2%)	were	primigravidas.	BMI	
during	 the	first	 trimester	was	within	 the	normal	 range	(19.8-26	
kg/m2)	for	326	(54.3%)	of	the	women.	516	(86%)	did	not	have	
a	history	of	abortion	and	332	(55.3%)	did	not	have	a	history	of	
delivery.	Analysis	of	the	different	groups	(in	terms	of	hemoglobin	
levels)	did	not	 indicate	any	significant	differences	among	them	
regarding	the	above	variables,	as	well	as	the	type	and	duration	of	
complement	intake	in	pregnancy	(p>0.05).
As	 Table	 II	 depicts,	 49	 (8.2%)	 of	 all	 cases	 developed	
gestational	diabetes,	among	which	41	(83.67%	of	those	afflicted)	
were	in	the	High	group	(hemoglobin	levels	of	1.25	and	higher).	
Using	 the	 chi-square	 test,	 a	 statistically	 significant	 relationship	
was	 discovered	 between	 high	 hemoglobin	 levels	 during	 the	
first	trimester	of	pregnancy	and	developing	gestational	diabetes	
(p=0.001).	The	 relative	 risk	 of	 developing	 gestational	 diabetes	
was	 3.94	 times	 higher	 for	 the	 High	 group	 compared	 to	 the	
Normal	group	(CI=1.74-8.95),	while	it	was	1.03	times	higher	for	
the	Low	group	compared	 to	 the	Normal	group	 (CI=0.12-8.17).	
Having	performed	the	Bonferroni	correction,	the	chi-square	test	
indicated	a	significant	difference	between	the	High	and	Normal	
hemoglobin	 groups;	 i.e.	 gestational	 diabetes	 occurred	 more	
frequently	in	the	High	hemoglobin	group	(p<0.001).	Comparison	
of	Low	and	Normal	hemoglobin	groups	with	chi-square	test	failed	
to	indicate	any	significant	difference	in	terms	of	the	occurrence	of	
gestational	diabetes	(p=0.3).		
Moreover,	comparing	the	High	and	Low	hemoglobin	groups	
with	chi-square	test	indicated	a	significant	difference	between	the	
two	groups	in	terms	of	the	development	of	gestational	diabetes	
(p=0.008).	The	incidence	of	gestational	diabetes	was	8.2%	in	our	
study,	with	confidence	interval	of	5-10%.
Table I. Demographic and obstetric characteristics of study cases.
H e m o g l o b i n  ( g / L )
Group <1.1n(30)
1.1-1.24
n(217)
≥1.25
n(353) Statistical Test p value
Age 28.23±  4.1 27.01 ±3.86 27.32± 3.97 One way ANOVA NS
Education (Intermediate/High 
School) (66.7%) (74.7%) (67.1%) Kruskall-Wallis NS
Occupation (Housewife) 11 (36.7) 78 (35.9) 123 (34.8) Chi-square NS
Number of Pregnancies 1.83± 0.69 1.7± 0.69 1.58± 0.67 Kruskall-Wallis 0.03
Number of Deliveries 0.7± 0.59 0.55± 0.61 0.44± 0.58 Kruskall-Wallis 0.01
Body Mass Index in First 
Trimester 24.31± 3.94 24.87± 4.4 25.11± 4.39 One way ANOVA NS
Body Mass Index in Third 
Trimester 29.41± 3.87 29.56± 4.15 30.02± 4.17 One way ANOVA NS
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A	ROC	curve	was	used	to	determine	the	appropriate	cut-off	
point	for	hemoglobin	test	during	the	first	trimester	of	pregnancy.	
As	Diagram	1	depicts,	the	ideal	cut-off	point	for	hemoglobin	test	
of	the	first	trimester	was	calculated	to	be	12.52	g/dL	with	the	area	
under	the	curve	equal	to	0.67.	According	to	the	data	of	this	table,	
first	trimester	hemoglobin	has	a	sensitivity	of	83.67%,	specificity	
of	47.73%,	and	positive	predictive	value	of	12.46%	and	negative	
predictive	 value	 of	 97.05%	 for	 early	 diagnosis	 of	 gestational	
diabetes.
Risk	factors	for	gestational	diabetes	were	assessed	using	the	
logistic	regression	model.	As	Table	3	illustrates,	our	investigation	
indicates	that	for	every	1	unit	rise	in	hemoglobin	level	of	the	first	
trimester,	there	is	a	1.76-fold	increase	in	the	risk	of	developing	
gestational	diabetes.	(Table	III).
Discussion
The	present	study	indicated	that	high	levels	of	hemoglobin	in	
the	first	trimester	of	pregnancy	and	progression	of	pregnancy	are	
significantly	related.	Phaloprakarn	et	al.,	(2008)	reported	similar	
results	 (CI=2.0-7.1,	RR=3.8)	 [3],	 as	well	 as	Lao	 et	 al.,	 (2002)	
whose	results	were	similar	to	those	of	our	study	(CI=1.08-2.78,	
RR=1.73)	[22].	The	findings	of	a	study	by	Vasegh	et	al.,	indicated	
that	high	hemoglobin	levels	before	14	weeks	of	gestational	age	
may	be	considered	to	be	a	risk	factor	for	developing	gestational	
diabetes,	what	may	 be	 accounted	 for	 by	 increased	 amounts	 of	
iron	stored	in	these	women.	
On	 the	 other	 hand,	 Gungor	 et	 al.,	 (2007)	 [23]	 did	 not	
observe	 a	 significant	 relationship	 between	 high	 hemoglobin	
levels	 of	 the	 first	 trimester	 and	 gestational	 diabetes.	However,	
many	confounding	variables	were	not	controlled	in	the	Gungor	
Table II. Distribution of absolute and relative frequency of pregnant women referred to the Milad Hospital in three hemoglobin groups and occurrence of gestational diabetes in 
2010.
H e m o g l o b i n  ( g / 1 0 0  m L )
Group <11 11-12.4 ≥12.5 Total
Gestational Diabetes Number (%) Number (%) Number (%) Number (%)
Yes 29 (96.7) 210 (96.8) 312 (88.4) 551 (91.8)
No 1 (3.3) 7 (3.2) 41 (11.6) 49 (8.2)
Total ( 100 ) 30 ( 100 ) 217 ( 100 ) 353 ( 100 ) 600
RR* (CI 95%) 1.03(0.12-8.71) 1 (Reference) 3.94(1.74-8.95)
* Relative risk
Table III. Risk factors for gestational diabetes using logistic regression model
                                                     Indices
Related Factors RR p value
Confidence 
Interval
Hemoglobin 1.76 0.001 1.26-2.46
Duration of Iron Intake during Pregnancy 1.37 0.03 1.02-1.84
Duration of Calcium Intake during 
Pregnancy 0.95 0.5 0.83-1.1
Fasting Blood Sugar in First Trimester 1.03 2 1.01-1.05
Fasting Blood Sugar in Second Trimester 1.05 0.001 1.03-1.08
Body Mass Index in First Trimester 1.05 0.4 0.92-1.2
Body Mass Index in Third Trimester 1.07 0.04 1-1.14
Figure 1. ROC curve for the first trimester hemoglobin in early diagnosis of 
gestational diabetes.
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study	 and	hemoglobin	 levels	were	 assessed	 in	 28-30	weeks	of	
gestations,	when	the	iron	supplements	received	during	the	second	
half	of	pregnancy	had	probably	obscured	the	true	difference	of	
hemoglobin	 level	 among	 the	 groups.	 Our	 study	 controlled	 the	
confounding	 variables	 appropriately	 and	 assessed	 hemoglobin	
levels	during	the	first	trimester.	
The	 probable	 mechanism	 accounting	 for	 the	 relationship	
between	excessive	hemoglobin	and	development	of	gestational	
diabetes	 is	 that	 the	 increased	 iron	may	 affect	 insulin	 synthesis	
and	 secretion,	 as	well	 as	 promote	 lipid	 oxidation,	 leading	 to	 a	
decreased	 glucose	 uptake	 and	 consumption	 in	 muscles	 and	
increased	glucose	synthesis	in	the	liver.		This	condition	creates	a	
state	of	insulin	resistance	and	makes	the	pregnant	woman	more	
prone	to	gestational	diabetes.	Furthermore,	increased	iron	stores	
influence	the	oxidative	stress	and	may	result	in	lipid	peroxidation	
and	 tissue	 injury	 through	 creation	of	 highly	 toxic	 free	 radicals	
such	 as	 superoxide	 and	 hydroxide	 anions.	 Oxidative	 stress	
increases	ferritin	so	that	the	higher	levels	of	ferritin	may	neutralize	
free	 iron	and	 reduce	 the	oxidative	 injury.	 It	 appears	 that	 tissue	
deposition	of	iron	promotes	insulin	resistance,	increasing	ferritin	
and	establishing	a	vicious	cycle	of	iron	overload	which	renders	
the	patient	prone	 to	glucose	 tolerance	disorder.	 Iron	deposition	
may	 simultaneously	 lead	 to	 subclinical	 hemochromatosis,	 thus	
compromising	pancreas	[24,	25].
It	 seems	 that	 high	 levels	 of	 hemoglobin	 during	 the	 first	
trimester	may	be	a	warning	sign	for	development	of	gestational	
diabetes	over	the	next	weeks	of	pregnancy.
Occurrence	of	certain	medical	conditions,	such	as	abortion	
before	20	weeks	of	gestation	and	the	consequent	exclusion	of	the	
person	was	among	the	limitations	of	the	present	study.	The	main	
advantage	 of	 the	 present	 study	 is	 its	 prospective	methodology,	
with	elimination	of	known	risk	factors	and	control	of	confounding	
variables	for	the	development	of	gestational	diabetes.	In	order	to	
enhance	the	reliability	and	validity	of	test	results,	all	tests	were	
performed	at	the	laboratory	of	the	Milad	Hospital	by	one	person	
and	with	one	instrument.	As	was	mentioned	in	the	method	section,	
reliability	 and	 validity	 were	 assessed.	 Discovering	 a	 new	 risk	
factor	for	early	diagnosis	of	gestational	diabetes	may	contribute	
to	early	detection	of	pregnant	women	at	risk.	Moreover,	timely	
treatment	or	 referral	 of	 patients	 afflicted	may	 reduce	maternal,	
fetal	and	neonatal	complications.	
Conclusion
It	appears	that	hemoglobin	level	during	the	first	trimester	of	
pregnancy	may	be	considered	as	a	selective	screening	factor	for	
gestational	diabetes.
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